Hospital Glucose Meter Standard Not Recognized By FDA, Agency Clarifies
This article was originally published in The Gray Sheet
Executive Summary
FDA says a 2013 Clinical and Laboratory Standards Institute standard for hospital glucose testing was never meant to be recognized by the agency, despite a July listing.
You may also be interested in...
First Glucose Meter Cleared For Hospital ICUs As FDA Continues Work On Guidance
FDA hopes the clearance of Nova Biomedical’s Nova StatStrip blood glucose monitor for hospitalized patients will help alleviate fears that increased regulatory standards will restrict critically ill patients’ access to point-of-care glucose testing. But the clearance does not necessarily settle the agency’s long-term policy plans for hospital-use glucose meters.
FDA Catches Heat For Plans To Raise Standards For Hospital Glucose Meters
An FDA draft guidance issued earlier this year on hospital glucose meters has attracted an unusual amount of attention, including criticism from clinicians, companies and others who worry it could cut off access to point-of-care glucose testing in patient cases where it is needed. The agency says it is taking appropriate measures to address a safety issue, and that some of the criticism is misdirected.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”